Defining the correlation between immune-checkpoint inhibitors-related adverse events and survival outcomes: A systematic review and meta-analysis

被引：0
|
作者：
Abdihamid, O. [1 ]
机构：
[1] Cent South Univ, CSU, Xiangya Sch Med, Oncol Dept, New Campus, Changsha, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.098
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
80P
引用
收藏
页码：S1406 / S1407
页数：2
相关论文
共 50 条
  • [21] Prognostic impact of sarcopenia on immune-related adverse events in malignancies received immune checkpoint inhibitors: a systematic review and meta-analysis
    Li, Shuluan
    Wang, Tianyu
    Lai, Wenjuan
    Zhang, Mingying
    Cheng, Boran
    Wang, Shubin
    Tong, Gangling
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (12) : 5150 - 5158
  • [22] Risk and incidence of fatal adverse events associated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Jiang, Yi
    Zhang, Ning
    Pang, Hailin
    Gao, Xiaobo
    Zhang, Helong
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2019, 15 : 293 - 302
  • [23] Immune-checkpoint inhibitors in anal squamous cell carcinoma: a systematic review and meta-analysis
    Pala, Laura
    De Pas, Tommaso
    Stucchi, Erika
    Catania, Chiara
    Cocorocchio, Emilia
    Zampino, Maria Giulia
    Rossi, Giovanna
    Zattarin, Emma
    Di Muzio, Antonio
    Laszlo, Daniele
    Stucchi, Sara
    Conforti, Fabio
    SEMINARS IN ONCOLOGY, 2023, 50 (06) : 140 - 143
  • [24] Immune-related adverse events and their effects on survival outcomes in patients with non-small cell lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis
    Liang, Yuxiang
    Xu, Haidi
    Liu, Futao
    Li, Lei
    Lin, Chenxi
    Zhang, Yaozhong
    Wang, Na
    Wang, Lei
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [25] Dermatologic adverse events with immune checkpoint blockade: Systematic review and meta-analysis
    Naha, Kushal
    Chintalacheruvu, Lakshmi Manogna
    Doll, Donald C.
    Naha, Sowjanya
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [26] Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis
    Pala, Laura
    Pagan, Eleonora
    Sala, Isabella
    Oriecuia, Chiara
    Oliari, Matteo
    De Pas, Tommaso
    Specchia, Claudia
    Cocorocchio, Emilia
    Zattarin, Emma
    Rossi, Giovanna
    Catania, Chiara
    Ceresoli, Giovanni Luca
    Laszlo, Daniele
    Canzian, Jacopo
    Valenzi, Elena
    Viale, Giuseppe
    Gelber, Richard D.
    Mantovani, Alberto
    Bagnardi, Vincenzo
    Conforti, Fabio
    ECLINICALMEDICINE, 2024, 73
  • [27] Treatment-related adverse events of combined anti-angiogenic and immune checkpoint inhibitors: systematic review and meta-analysis
    Lian Chen
    Ling Wu
    Zhang Lu
    Qin Huang
    Liu Huang
    Oncology and Translational Medicine, 2022, 8 (06) : 301 - 310
  • [28] Treatment-related adverse events of combination immune checkpoint inhibitors: Systematic review and meta-analysis.
    Park, Robin
    da Silva, Laercio Lopes
    Riano, Ivy
    Cristancho, Cagney
    Saeed, Anwaar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors
    Serino, M.
    Freitas, C.
    Martins, M.
    Ferreira, P.
    Cardoso, C.
    Veiga, F.
    Santos, V.
    Araujo, D.
    Novais-Bastos, H.
    Magalhaes, A.
    Queiroga, H.
    Fernandes, G.
    Hespanhol, V.
    PULMONOLOGY, 2024, 30 (04): : 352 - 361
  • [30] Treatment-related adverse events of immune checkpoint inhibitors combined with angiogenesis inhibitors in advanced lung cancer: A systematic review and meta-analysis
    Zheng, Yumin
    Dong, Huijing
    Yu, Yixuan
    Hu, Zixin
    Xue, Chongxiang
    Zhang, Xu
    Cui, Huijuan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 123
12345